Yuanli Chemical Group Co.,Ltd.

SHSE:603217 Voorraadrapport

Marktkapitalisatie: CN¥3.7b

Yuanli Chemical GroupLtd Toekomstige groei

Future criteriumcontroles 5/6

Yuanli Chemical GroupLtd is forecast to grow earnings and revenue by 26.3% and 22.6% per annum respectively. EPS is expected to grow by 25.8% per annum. Return on equity is forecast to be 10.3% in 3 years.

Belangrijke informatie

26.3%

Groei van de winst

25.8%

Groei van de winst per aandeel

Chemicals winstgroei38.3%
Inkomstengroei22.6%
Toekomstig rendement op eigen vermogen10.3%
Dekking van analisten

Low

Laatst bijgewerkt21 Apr 2024

Recente toekomstige groei-updates

Geen updates

Recent updates

Yuanli Chemical GroupLtd (SHSE:603217) Will Want To Turn Around Its Return Trends

Oct 23
Yuanli Chemical GroupLtd (SHSE:603217) Will Want To Turn Around Its Return Trends

Take Care Before Diving Into The Deep End On Yuanli Chemical Group Co.,Ltd. (SHSE:603217)

Sep 28
Take Care Before Diving Into The Deep End On Yuanli Chemical Group Co.,Ltd. (SHSE:603217)

Yuanli Chemical GroupLtd's (SHSE:603217) Shareholders Have More To Worry About Than Only Soft Earnings

Apr 23
Yuanli Chemical GroupLtd's (SHSE:603217) Shareholders Have More To Worry About Than Only Soft Earnings

Yuanli Chemical Group Co.,Ltd.'s (SHSE:603217) Shares Bounce 26% But Its Business Still Trails The Market

Mar 07
Yuanli Chemical Group Co.,Ltd.'s (SHSE:603217) Shares Bounce 26% But Its Business Still Trails The Market

Winst- en omzetgroeiprognoses

SHSE:603217 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (CNY Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/20263,672411N/A3061
12/31/20252,750319N/A3241
12/31/20242,371258N/A3501
9/30/20242,216223-346-237N/A
6/30/20242,226230-200-106N/A
3/31/20242,170241-207-88N/A
12/31/20232,181250-4566N/A
9/30/20232,233255125178N/A
6/30/20232,273296293329N/A
3/31/20232,487399454465N/A
12/31/20222,683469376468N/A
9/30/20222,762484313438N/A
6/30/20222,817484163360N/A
3/31/20222,6444121207N/A
12/31/20212,34336039163N/A
9/30/20212,08232151185N/A
6/30/20211,713264116166N/A
3/31/20211,432212124167N/A
12/31/20201,222158110156N/A
9/30/20201,126125-2102N/A
6/30/20201,0901181982N/A
3/31/20201,1091211196N/A
12/31/20191,167136-1578N/A
9/30/20191,2161622277N/A
6/30/20191,301204-14107N/A
3/31/20191,335222-27129N/A
12/31/20181,367242-42159N/A
12/31/20171,248185N/A242N/A
12/31/2016932157N/A122N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: 603217's forecast earnings growth (26.3% per year) is above the savings rate (2.9%).

Winst versus markt: 603217's earnings (26.3% per year) are forecast to grow faster than the CN market (25.8% per year).

Hoge groeiwinsten: 603217's earnings are expected to grow significantly over the next 3 years.

Omzet versus markt: 603217's revenue (22.6% per year) is forecast to grow faster than the CN market (14% per year).

Hoge groei-inkomsten: 603217's revenue (22.6% per year) is forecast to grow faster than 20% per year.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: 603217's Return on Equity is forecast to be low in 3 years time (10.3%).

Ontdek groeibedrijven

7D

1Y

7D

1Y

7D

1Y